Apollo Care recalls semaglutide multi-dose vials over particles found in the product
The vials contain particulate matter, which the notice identifies as a nylon/polyamide and silk/proteinaceous-type material.
What to do
The notice does not give instructions. Read the official notice for details.
Note from Recalled Today: Don't stop taking a prescribed medicine before you talk to your pharmacist or doctor.
Recall details
- Product
- SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-721-01; SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-495-05; SEMAGLUTIDE…
- Company
- Apollo Care, LLC
- Hazard
- Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
- Units
- 250 vials.; 56,918 vials.; 23,029 vials.
- Where sold
- Nationwide within the U.S
- FDA classification
- Class II · Ongoing
- Classified by FDA
- August 7, 2026
- Recall started
- July 29, 2026
- FDA enforcement report
- August 19, 2026
- Identifiers
- Codes: Lot: AC-017273, Exp. 12/12/2026.
- FDA recall number: D-0755-2026
- Codes: Lot: AC-017108, Exp. 11/17/2026; AC-017110, Exp. 11/20/2026; AC-017112, Exp. 11/21/2026; AC-017142, AC-017144, Exp. 12/10/2026; AC-017166, AC-017167, AC-017177, AC-017213, AC-017224, AC-017225, Exp. 12/31/2026
- FDA recall number: D-0747-2026
- Codes: Lot: AC-017114, Exp. 11/24/2026; AC-017164, AC-017204, AC-017205, Exp. 12/31/2026.
- FDA recall number: D-0748-2026
- Codes: Lot: AC-017271, Exp. 12/12/2026.
- FDA recall number: D-0753-2026
- Codes: Lot: C-017115, Exp. 11/25/2026; AC-017163, Exp. 12/31/2026; AC-017169, AC-017170, AC-017171, Exp. 12/31/2026; AC-017230, AC-017231, Exp. 5/5/2027.
- FDA recall number: D-0749-2026
- Codes: Lot: AC-017131, Exp. 8/30/2026.
- FDA recall number: D-0752-2026
The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.
Official notice
The notice's own wording from FDA.
- Product
- SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-721-01 | SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-495-05 | SEMAGLUTIDE 2.25MG (0.9 mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202 NDC 71170-811-02 | SEMAGLUTIDE 2.5mg (1mg/mL), Glycine 12.5 mg (5mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-711-02
- Reason for recall
- Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
- Classification
- Class II (Ongoing)
- Distribution
- Nationwide within the U.S
- Quantity
- 250 vials.; 56,918 vials.; 23,029 vials.; 37,546 vials.; 4,748 vials.; 4,250 vials.
Related recalls
Novo Nordisk recalls Wegovy injection pens over a hair found in a prefilled syringe
A hair was found in a prefilled syringe of Wegovy (semaglutide) injection, so the 1 mg/0.5 mL and 0.5 mg/0.5 mL four-pen packs may contain foreign particles.